Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide pharmacodynamic study in Friedreich's ataxia
2011-002744-27Phase 2Unknown
- Sponsor
- Imperial College London
- Start
- Sep 2011
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Nicobion in Friedreich ataxia (FA), sponsored by Imperial College London. Primary endpoint: Frataxin levels. Status: unknown.
02
Drugs
Nicobion
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2011-002744-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002744-27.